Hydroxyzine pamoate
Hydroxyzine Pamoate is a prescription antihistamine medication available as oral capsules in 25 mg and 50 mg strengths (equivalent to 25 mg and 50 mg hydroxyzine hydrochloride). It works by blocking histamine receptors and is used to treat conditions like anxiety, itching, and allergies. Manufactured by Heritage Pharmaceuticals and Chartwell RX, LLC, under ANDA 201507. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Hydroxyzine Pamoate is a prescription antihistamine medication available as oral capsules in 25 mg and 50 mg strengths (equivalent to 25 mg and 50 mg hydroxyzine hydrochloride). It works by blocking histamine receptors and is used to treat conditions like anxiety, itching, and allergies. Manufactured by Heritage Pharmaceuticals and Chartwell RX, LLC, under ANDA 201507. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Hydroxyzine pamoate",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Hydroxyzine pamoate — ANDA 201507 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201507"
}
]
|
| identifier | ANDA201507 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"drug-safety",
"pharmaceuticals",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Hydroxyzine pamoate |
